(Q41459314)

1 October 2017

title

Effect of homologous and heterologous prime-boost on the immune response to recombinant plague antigens (English)

1 reference

1 October 2017

Audrey Glynn

1

1 reference

1 October 2017

Lucy C Freytag

series ordinal

2

1 reference

1 October 2017

John D Clements

series ordinal

3

1 reference

1 October 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

1 October 2017

1 reference

1 October 2017

volume

23

1 reference

1 October 2017

issue

16

1 reference

1 October 2017

page(s)

1957-1965

1 reference

An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four inbred strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

Vaccination against bubonic and pneumonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

Presentation of protective antigen to the mouse immune system: immune sequelae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

A single dose sub-unit vaccine protects against pneumonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

Flea-borne transmission model to evaluate vaccine efficacy against naturally acquired bubonic plague.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

Interplay of cytokines and adjuvants in the regulation of mucosal and systemic HIV-specific CTL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

Functional mapping of protective domains and epitopes in the rotavirus VP6 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

LT(R192G), a non-toxic mutant of the heat-labile enterotoxin of Escherichia coli, elicits enhanced humoral and cellular immune responses associated with protection against lethal oral challenge with Salmonella spp.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

Human papillomavirus virus-like particles are efficient oral immunogens when coadministered with Escherichia coli heat-labile enterotoxin mutant R192G or CpG DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

Adjuvant activity of a nontoxic mutant of Escherichia coli heat-labile enterotoxin on systemic and mucosal immune responses elicited against a heterologous antigen carried by a live Salmonella enterica serovar Typhimurium vaccine strain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

Mucosal immunization of mice using CpG DNA and/or mutants of the heat-labile enterotoxin of Escherichia coli as adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

Effectiveness of intranasal immunization with HIV-gp160 and an HIV-1 env CTL epitope peptide (E7) in combination with the mucosal adjuvant LT(R192G)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

Active immunity and T-cell populations in pigs intraperitoneally inoculated with baculovirus-expressed transmissible gastroenteritis virus structural proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

The role of cAMP in mucosal adjuvanticity of Escherichia coli heat-labile enterotoxin (LT)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

Transcutaneous immunization: a human vaccine delivery strategy using a patch

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

Transcutaneous immunization induces mucosal and systemic immunity: a potent method for targeting immunity to the female reproductive tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

Immunostimulant patch enhances immune responses to influenza virus vaccine in aged mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

Determination of the virulence of the pigmentation-deficient and pigmentation-/plasminogen activator-deficient strains of Yersinia pestis in non-human primate and mouse models of pneumonic plague.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

Intranasal immunization with liposome-formulated Yersinia pestis vaccine enhances mucosal immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

Generation of Yersinia pestis attenuated strains by signature-tagged mutagenesis in search of novel vaccine candidates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

Oral immunisation with live aroA attenuated Salmonella enterica serovar Typhimurium expressing the Yersinia pestis V antigen protects mice against plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

Salmonella enterica serovar typhimurium expressing a chromosomally integrated copy of the Bacillus anthracis protective antigen gene protects mice against an anthrax spore challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

A Salmonella enterica serovar Typhi vaccine expressing Yersinia pestis F1 antigen on its surface provides protection against plague in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

Plague vaccine research and development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

Local and systemic immune response to a microencapsulated sub-unit vaccine for plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

The F1 and V subunit vaccine protects against plague in the absence of IL-4 driven immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

Improvement of the systemic prime/oral boost strategy for systemic and local responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

Effect of priming/booster immunisation protocols on immune response to canine parvovirus peptide induced by vaccination with a chimaeric plant virus construct

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

Immunity to experimental cholera. III. Enhanced duration of protection after sequential parenteral-oral administration of toxoid to dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

Memory T cells and vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

7 January 2021

inferred from DOI database lookup

Antibody-dependent and -independent protection following intranasal immunization of mice with rotavirus particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

7 January 2021

inferred from DOI database lookup

Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.025

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/J.VACCINE.2004.10.025

1 reference

release_harwvaq2d5f2poipdrhvad4cdm

1 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/harwvaq2d5f2poipdrhvad4cdm

24 November 2022

mapped directly with Wikidata item

1 reference